Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
242.50    7.50 (3.19%)
Bid:
240.00
Ask:
245.00
Spread: 5.00 (2.083%)
Market Cap: £87.20m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Acquisition

1 May 2007 15:28

Alumasc Group PLC01 May 2007 Tuesday 1 May 2007 THE ALUMASC GROUP PLC ALUMASC ACQUIRES LEVOLUX FOR £13.5 MILLION Alumasc (ALU.L), the premium building and engineering products company,announces the acquisition of Levolux Limited and Levolux AT Limited (together,"Levolux"), the UK's leading supplier of solar shading systems for buildings,for a total consideration of £13.5 million. Consideration The consideration will be satisfied by the payment of £12.3 million in cash andthe issue to the vendors of 541,760 new ordinary shares in the Companyequivalent to £1.2 million at a share price of 221.5p1. The vendors of Levoluxhave undertaken not to sell any of the new ordinary shares for a period of atleast 24 months. The £12.3 million cash consideration was met from a new fiveyear revolving credit facility provided by Lloyds TSB Bank plc. Levolux Levolux designs, manufactures and installs internal and external shading systemswhich are used to control the impact of sunlight on a building's internalenvironment. These systems, which include Brise Soleil, Aerofoil Fins, Louvres,External and Internal Blinds, are increasingly specified in new buildings andrefurbishment projects in order to improve energy performance and the comfort ofoccupants. As a result of working closely with architects and other specifiers,Levolux systems are frequently an integral part of a building's functional andaesthetic design. In the 11 months to 31 March 2007, Levolux's unaudited operating profit wasapproximately £2.5 million on turnover of £19 million, compared with auditedoperating profit of £514,000 (after deducting bonuses to the owners) on turnoverof £15.9 million for the year to 30 April 2006. At 30 April 2006, it had netassets of £1.8 million and gross assets of £6.6 million. Levolux operates from two leasehold sites, one in Harrow, Middlesex, and theother in Gloucester. It is Alumasc's intention to continue the development ofLevolux from its present sites. Reasons for the Acquisition The acquisition of Levolux fits at the core of Alumasc's strategy to develop thegroup's high performance building products activities. Alumasc is already asupplier to the building industry of 'sustainable' products such as Zinco greenroofs and Gatic Slotdrain. Levolux will add significantly to Alumasc's portfolioof sustainable building products and will grow the opportunity, believed to besubstantial, for developing markets for these products outside the UK. The existing team, including John and Pamela Stern, the two principalshareholders, will continue to manage Levolux. Chief Executive, Paul Hooper, commented:'The opportunity to acquire such a high quality brand leader in the sustainablebuilding products market does not often present itself. With the introduction of the updated Document L building regulations aimed atreducing the UK's carbon emissions in commercial buildings, Levolux is in astrong position to assist architects in meeting such important demands as wellas contributing to external and internal design aesthetics. We are excited towelcome Levolux into The Alumasc Group and we look forward to building on thesuccess of the business to expand further in the UK and overseas. Levolux willspearhead The Alumasc Group's growing presence in sustainable "green" buildingproducts'. Enquiries: The Alumasc Group PLC Tel: 01536 383844Paul Hooper, Chief ExecutiveAndrew Magson, Finance Director Bankside ConsultantsCharles Ponsonby Tel: 0207 367 8851 1 Application has been made for the new ordinary shares to be admitted to theOfficial List and admission is expected to take place on 8 May 2007. The newordinary shares will rank pari passu, in all respects, with the existing issuedordinary shares. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 20261:21 pmRNSHolding(s) in Company
21st Apr 20267:00 amRNSDirector Dealings
20th Apr 20262:37 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSQ3 Trading Update
1st Apr 20267:00 amRNSConfirmation of CEO appointment
9th Feb 20267:00 amRNS-RMelloMonday Investor Webinar
3rd Feb 20267:00 amRNSInterim Results
15th Jan 20267:00 amRNSDirectorate change
10th Dec 20259:36 amRNSNotice of Half Year Results
21st Nov 20252:17 pmRNSDirector/PDMR Shareholding
7th Nov 202511:22 amRNSDirector/PDMR Shareholding
5th Nov 20252:50 pmRNSDirector/PDMR Shareholding
4th Nov 202511:03 amRNSDirector/PDMR Shareholding
24th Oct 20251:52 pmRNSResult of AGM
24th Oct 20257:00 amRNSAGM Trading Update
23rd Sep 20257:00 amRNSCEO Retirement & 2025 AGM Notice & Annual Accounts
2nd Sep 20257:00 amRNSFinal Results - Unaudited
21st Jul 20257:00 amRNSNotice of FY Results and Investor Presentation
15th Jul 20257:00 amRNSFull Year Trading Update
11th Jun 20253:46 pmRNSDirector/PDMR Shareholding
27th May 20257:00 amRNSAppointment of Non-executive Director
4th Apr 20257:00 amRNS-ROpening new Wade/Gatic building extension
21st Mar 20257:00 amRNSAppointment of Joint Broker
12th Mar 202511:15 amRNSDirector/PDMR Shareholding
4th Feb 20257:00 amRNSHalf-year Results
27th Nov 202412:22 pmRNSNotice of Half Year Results
6th Nov 20241:40 pmRNSDirector/PDMR Shareholding
5th Nov 20248:00 amRNSDirector/PDMR Shareholding
1st Nov 202411:15 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSDirector/PDMR Shareholding
24th Oct 20241:38 pmRNSResult of AGM
24th Oct 20247:00 amRNSAGM Trading Update
23rd Oct 202412:53 pmRNSDirector/PDMR Shareholding
10th Oct 20247:00 amRNSNotice of Capital Markets Event
4th Oct 20247:00 amRNSDirectorate Change
20th Sep 20242:15 pmRNSNotice of AGM
18th Sep 20242:32 pmRNSDirector/PDMR Shareholding
3rd Sep 20247:00 amRNSFinal Results
25th Jul 20248:00 amRNSNotice of Results
18th Jul 20247:00 amRNSFull Year Trading Update
25th Apr 20249:38 amRNSHolding(s) in Company
27th Feb 202412:31 pmRNSDirector/PDMR Shareholding
14th Feb 20241:01 pmRNSDirector/PDMR Shareholding
6th Feb 20247:00 amRNSInterim results
11th Jan 20247:00 amRNSNotice of Interim Results
3rd Jan 202412:52 pmRNSDirector/PDMR Shareholding
19th Dec 20239:50 amRNSDirector/PDMR Shareholding
18th Dec 20233:17 pmRNSDirector/PDMR Shareholding
18th Dec 20231:23 pmRNSDirector/PDMR Shareholding
18th Dec 20231:10 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.